iifl-logo-icon 1

Dishman Carbogen Amcis Ltd Share Price

167.95
(0.11%)
Jul 16, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open167.01
  • Day's High170.8
  • 52 Wk High283
  • Prev. Close167.77
  • Day's Low167.01
  • 52 Wk Low133
  • Turnover (lac)413.26
  • P/E0
  • Face Value2
  • Book Value257.55
  • EPS0
  • Mkt. Cap (Cr.)2,633.17
  • Div. Yield0
No Records Found

Dishman Carbogen Amcis Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

167.01

Prev. Close

167.77

Turnover(Lac.)

413.26

Day's High

170.8

Day's Low

167.01

52 Week's High

283

52 Week's Low

133

Book Value

257.55

Face Value

2

Mkt Cap (₹ Cr.)

2,633.17

P/E

0

EPS

0

Divi. Yield

0

Dishman Carbogen Amcis Ltd Corporate Action

24 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

22 Aug 2023

12:00 AM

AGM

Announcement Date: 22 Aug, 2023

arrow

Dishman Carbogen Amcis Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Dishman Carbogen Amcis Ltd SHAREHOLDING SNAPSHOT

18 Jul, 2024|06:48 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 59.32%

Foreign: 0.00%

Indian: 59.32%

Non-Promoter- 11.06%

Institutions: 11.06%

Non-Institutions: 29.61%

Custodian: 0.00%

Share Price

Dishman Carbogen Amcis Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

31.36

31.36

31.36

31.38

Preference Capital

0

0

0

0

Reserves

4,082.95

4,200.42

4,643.26

4,764.47

Net Worth

4,114.31

4,231.78

4,674.62

4,795.85

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

208.01

580.74

474.46

451.49

yoy growth (%)

-64.18

22.4

5.08

6,529.8

Raw materials

-108.44

-200.11

-155.31

-142.07

As % of sales

52.13

34.45

32.73

31.46

Employee costs

-59.4

-88.87

-61.67

-66.76

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

-168.69

55.46

62.17

43.91

Depreciation

-143.21

-140.65

-134.45

-135.85

Tax paid

-64.12

-16.94

-25.1

-19.67

Working capital

0.78

29.87

52.04

419.05

Other operating items

View Cash Flow
Loading...

No Record found

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

2,615.77

2,412.92

2,140.69

1,912.03

2,043.6

Excise Duty

0

0

0

0

0

Net Sales

2,615.77

2,412.92

2,140.69

1,912.03

2,043.6

Other Operating Income

0

0

0

0

0

Other Income

28.21

27.77

43.42

38.45

44.46

Dishman Carbogen Amcis Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,579.3

124.153,78,914.98867.60.855,536.9998.75

Cipla Ltd

CIPLA

1,510.4

32.861,22,044.231,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,570.8

76.931,21,185.085310.662,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,184.8

34.691,19,223.631,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,646.05

25.871,10,827.471,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Dishman Carbogen Amcis Ltd

Management

Register Office

Registrar Office

Chairman (Non-Executive)

Janmejay R Vyas

Whole-time Director

Deohooti J Vyas

Managing Director & CFO

Arpit J Vyas

Independent Director

Sanjay S Majmudar

Independent Director

Ashok C Gandhi

Independent Director

Subir Kumar Das

Independent Director

Rajendra S Shah

Company Sec. & Compli. Officer

Shrima Dave

Independent Director

Maitri K Mehta

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Dishman Carbogen Amcis Limited was incorporated in the year July 17, 2007. The Company is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries. It has manufacturing and research facilities in India, Switzerland, France, The Netherland and China. As on 31st March 2019, the total number of subsidiaries including step down subsidiaries were 14.During the financial year ended 31 March 2017, Dishman Pharmaceuticals and Chemicals Limited (DPCL) and Dishman Care Limited were merged with DPCLs subsidiary Carbogen Amcis (India) Limited, with the key objective of business consolidation and simplification of the Group structure. The name of Carbogen Amcis (India) Ltd. was changed to Dishman Carbogen Amcis Ltd. with effect from 27 March 2017.Dishman Pharmaceuticals and Chemicals Ltd was incorporated in the year 1983 as a research-oriented organization. The company set up their first manufacturing unit in Naroda for phase Transfer Catalysts. The company earned the status of Quat Company by establishing themselves in the Quat business.In the year 1995, the company formed a joint venture company with Schtz & Co, Germany called as Schutz Dishman Biotech Private Ltd. They manufacture Chlorhexidine Base, Chlorhexidine HCl, Chlorhexidine Acetate and Chlorhexidine Gluconate solution, for the European
Read More

Company FAQs

What is the Dishman Carbogen Amcis Ltd share price today?

Down Arrow

The Dishman Carbogen Amcis Ltd shares price on N/A is Rs.₹167.95 today.

What is the Market Cap of Dishman Carbogen Amcis Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dishman Carbogen Amcis Ltd is ₹2633.17 Cr. as of 16 Jul ‘24

What is the PE and PB ratio of Dishman Carbogen Amcis Ltd?

Down Arrow

The PE and PB ratios of Dishman Carbogen Amcis Ltd is 0 and 0.65 as of 16 Jul ‘24

What is the 52 Week High and Low of Dishman Carbogen Amcis Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Dishman Carbogen Amcis Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Dishman Carbogen Amcis Ltd is ₹132.75 and ₹282.95 as of 16 Jul ‘24

What is the CAGR of Dishman Carbogen Amcis Ltd?

Down Arrow

Dishman Carbogen Amcis Ltd's CAGR for 5 Years at -5.17%, 3 Years at -7.65%, 1 Year at 20.91%, 6 Month at -12.50%, 3 Month at -25.90% and 1 Month at -4.41%.

What is the shareholding pattern of Dishman Carbogen Amcis Ltd?

Down Arrow

The shareholding pattern of Dishman Carbogen Amcis Ltd is as follows:
Promoters - 59.32 %
Institutions - 12.29 %
Public - 28.39 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.